Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Davis

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Plos One|April 21, 2017
Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumptionDavid J Marcus, Angela N Henderson-Redmond, Maciej Gonek, et al.
Plos One|August 9, 2016
Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor DiabeticDavid J Marcus, Michael L Zee, Brian J Davis, et al.
Plos One|October 11, 2008
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyTohru Nakagawa, Thomas M Kollmeyer, Bruce W Morlan, et al.
The Journal of Urology|May 28, 2013
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO GuidelineIan M Thompson, Richard K Valicenti, Peter Albertsen, et al.
The Journal of Urology|September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance ImagingAvinash Nehra, William P Parker, Rimki Haloi, et al.
NPJ Digital Medicine|December 18, 2025
Personalizing prostate cancer education for patients using an EHR-Integrated LLM agentYuexing Hao, Jason Holmes, Mark R Waddle, et al.
International Journal of Particle Therapy|June 3, 2024
Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate CancerRobert W Gao, Jiasen Ma, Thomas M Pisansky, et al.
International Journal of Particle Therapy|September 30, 2024
ACR-ARS Practice Parameter for the Performance of Proton Beam TherapySteven J Frank, Indra J Das, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2022
Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate CancerRichard Choo, David W Hillman, Cecilia Mitchell, et al.
American Journal of Clinical Oncology|June 20, 2025
ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT)Adam Garsa, Courtney R Buckey, Brian J Davis, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Plos One|April 21, 2017
Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumptionDavid J Marcus, Angela N Henderson-Redmond, Maciej Gonek, et al.
Plos One|August 9, 2016
Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor DiabeticDavid J Marcus, Michael L Zee, Brian J Davis, et al.
Plos One|October 11, 2008
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyTohru Nakagawa, Thomas M Kollmeyer, Bruce W Morlan, et al.
The Journal of Urology|May 28, 2013
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO GuidelineIan M Thompson, Richard K Valicenti, Peter Albertsen, et al.
The Journal of Urology|September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance ImagingAvinash Nehra, William P Parker, Rimki Haloi, et al.
NPJ Digital Medicine|December 18, 2025
Personalizing prostate cancer education for patients using an EHR-Integrated LLM agentYuexing Hao, Jason Holmes, Mark R Waddle, et al.
International Journal of Particle Therapy|June 3, 2024
Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate CancerRobert W Gao, Jiasen Ma, Thomas M Pisansky, et al.
International Journal of Particle Therapy|September 30, 2024
ACR-ARS Practice Parameter for the Performance of Proton Beam TherapySteven J Frank, Indra J Das, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2022
Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate CancerRichard Choo, David W Hillman, Cecilia Mitchell, et al.
American Journal of Clinical Oncology|June 20, 2025
ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT)Adam Garsa, Courtney R Buckey, Brian J Davis, et al.
Pageof 15